Western Europe’s PV selling rate continued its upward trend, reaching 13.1 million units/year, according to figures released by GlobalData.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

Acelyrin plans to initiate two Phase III studies this quarter, which will enrol up to 350 patients with thyroid eye disease ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

Novartis has announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) achieved the primary ...

Consumer hesitation around taste remains a main challenge to successfully marketing alternative food and drink products, says GlobalData.

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.